Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Schulte, P. F. J., and James H. MacCabe. "Clozapine: gold standard treatment for refractory schizophrenia: now or never?." In Treatment–Refractory Schizophrenia, pp. 81-91. Springer, Berlin, Heidelberg, 2014.

McEvoy, Joseph. "Current standard treatments." Future Medicine Ltd, 2012.

Hashimoto, Hitoshi, and Ryota Hashimoto. "Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine." (2016).

Faloba, Kathryn, Viwek S. Bisen, Anthony M. Tobia, Adam J. Trenton, and Aphrodite M. Zimmerman. "Sober today, but lethargic and confused." Current Psychiatry 14, no. 5 (2015): 45.

Wegener, Gregers. "Updated Practice Guidelines for the Use of Clozapine in Adult Individuals with Intellectual Disabilities." (2016).

Sakuma, Mutsuki, Fuminari Misawa, Midori Maeda, Yasuo Fujii, Hiroyuki Uchida, Masaru Mimura, and Hiroyoshi Takeuchi. "Development of Diagnostic Criteria and Severity Scale for Polydipsia: A Systematic Literature Review and Well-Experienced Clinicians’ Consensus." Psychiatry Research (2021): 113708.

Peechakara, Basil V., and Mohit Gupta. "Water Toxicity." StatPearls [Internet] (2020).

Lopes, Antonio T., Paul Gilluley, Mehdi Veisi, Shamir Patel, Seema Sukhwal, Joanna Dow, and Nagendra Bendi. "Management of treatment resistant schizophrenia in medium secure care." Progress in Neurology and Psychiatry 18, no. 5 (2014): 27-32.

Lyseng-Williamson, Katherine A. "Clozapine oral suspension (Versacloz™): a guide to its use in the USA." Drugs & Therapy Perspectives 30, no. 6 (2014): 193-199.

Benedetti?Isaac, Juan C., Martín Torres?Zambrano, Gabriel Alcalá?Cerra, and Juan J. Gutiérrez?Paternina. "Partial hypopituitarism: A sequel of extrapontine myelinosis." Neurology India 61, no. 3 (2013).

Correll, Christoph U., Thomas Brevig, and Cecilia Brain. "Exploration of treatment-resistant schizophrenia subtypes based on a survey of 204 US psychiatrists." Neuropsychiatric Disease and Treatment 15 (2019): 3461.

Docrat, Sumaiyah. "Economic costs, impacts and financing strategies for mental health in South Africa." (2020).

Bisen, Viwek S., and Anthony M. Tobia. "Sober today, but lethargic and confused."

Crocker, Candice E., and Philip G. Tibbo. "Confused connections? Targeting white matter to address treatment resistant schizophrenia." Frontiers in pharmacology 9 (2018): 1172.

Chue, Pierre, and Bogdan Neagu. "Antipsychotic Drugs." In Side Effects of Drugs Annual, vol. 36, pp. 59-84. Elsevier, 2014.

Sanz-Fuentenebro, Francisco Javier, Jose Juan Uriarte Uriarte, Pere Bonet Dalmau, Vicente Molina Rodriguez, and Miquel Bernardo Arroyo. "Patrón de uso de clozapina en España. Variabilidad e infraprescripción." Revista de Psiquiatría y Salud Mental 12, no. 3 (2019): 151-162.

Levine, Seymour, Arthur Saltzman, and Stephen D. Ginsberg. "Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia." Journal of Neuropathology & Experimental Neurology 70, no. 2 (2011): 151-156.

Urban, A., M. Wiglusz, W. Cubala, Jerzy Landowski, and Krzysztof Krysta. "Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine." Psychiatr Danub 27, no. Suppl 1 (2015): S459-S461.

Goldman, Morris, and Pichai Ittasakul. "Management of water imbalance in schizophrenia." In Schizophrenia, pp. 205-223. Springer, New York, NY, 2014.

Kim, Se Hyun, Hyun Sook Yu, Hong Geun Park, Soyoung Park, Myoung Suk Seo, Won Je Jeon, Yong Min Ahn, Kyooseob Ha, Soon Young Shin, and Yong Sik Kim. "Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex." Psychopharmacology 230, no. 3 (2013): 425-437.